Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | Flap nuclease, putative | 0.0027 | 0.249 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.1622 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.1622 | 0.6513 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.1622 | 0.1622 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.1098 | 0.1098 |
Echinococcus granulosus | flap endonuclease 1 | 0.0027 | 0.249 | 0.249 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.2601 | 0.2601 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.002 | 0.1622 | 0.5 |
Brugia malayi | Flap endonuclease-1 | 0.0027 | 0.249 | 0.249 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.2601 | 0.2601 |
Echinococcus multilocularis | lamin | 0.0028 | 0.2601 | 0.2601 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0027 | 0.249 | 0.249 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0092 | 1 | 1 |
Echinococcus granulosus | lamin | 0.0028 | 0.2601 | 0.2601 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0092 | 1 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.1622 | 0.6513 |
Plasmodium falciparum | flap endonuclease 1 | 0.0027 | 0.249 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.1622 | 0.5 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.2601 | 0.2601 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.2601 | 0.2601 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.2601 | 0.2601 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.1622 | 0.6513 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0.1622 | 0.6513 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0092 | 1 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.1622 | 0.1622 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.1622 | 0.1622 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.1622 | 0.6513 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0092 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.2542 | 0.2542 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0092 | 1 | 1 |
Schistosoma mansoni | lamin | 0.0028 | 0.2601 | 0.2601 |
Schistosoma mansoni | lamin | 0.0028 | 0.2601 | 0.2601 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0027 | 0.249 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.2601 | 0.2601 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.2601 | 0.2601 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.1622 | 0.6513 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0027 | 0.249 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.2601 | 0.2601 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.2601 | 0.2601 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0867 | 0.0867 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.1622 | 0.6513 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0927 | 0.0927 |
Onchocerca volvulus | 0.0028 | 0.2601 | 0.5 | |
Schistosoma mansoni | flap endonuclease-1 | 0.0025 | 0.219 | 0.219 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0027 | 0.249 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.1622 | 0.1622 |
Echinococcus multilocularis | musashi | 0.0028 | 0.2601 | 0.2601 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.1622 | 0.6513 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0027 | 0.249 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0092 | 1 | 1 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0027 | 0.249 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.1622 | 0.1622 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.1622 | 0.1622 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.1622 | 0.6513 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0092 | 1 | 1 |
Onchocerca volvulus | 0.0028 | 0.2601 | 0.5 | |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0027 | 0.249 | 0.249 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0027 | 0.249 | 1 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0014 | 0.0927 | 0.0927 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.1622 | 0.6513 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.002 | 0.1622 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0867 | 0.0867 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0014 | 0.0927 | 0.0927 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0015 | 0.1098 | 0.1098 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.1622 | 0.6513 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0092 | 1 | 1 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0027 | 0.249 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 10 % | Inhibition of human NPP1 using p-Nph-5'-TMP as substrate at 10 uM | ChEMBL. | 25372276 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.